How does MVF's PS Ratio compare to its peers?

MVF is expensive based on its Price-To-Sales Ratio (1.8x) compared to the peer average (1.5x).

How does MVF's PS Ratio compare vs other companies in the AU Healthcare Industry?

MVF is expensive based on its Price-To-Sales Ratio (1.8x) compared to the Oceanic Healthcare industry average (1.5x).

What is MVF's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MVF is expensive based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (1.2x).

What is the Fair Price of MVF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

MVF (A$1.17) is trading below our estimate of [[fair value]] (A$5.12)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Monash IVF Group (CHIA:MVF) - Stock Price, News & Analysis

MVF Stock Overview

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

About the company

MVF fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	0/6
Financial Health	3/6
Dividends	2/6

Rewards

Trading at 77.2% below our estimate of its fair value

Earnings are forecast to grow 48.1% per year

Analysts in good agreement that stock price will rise by 30.6%

Risk Analysis

Dividend of 4.29% is not well covered by earnings

Monash IVF Group Limited Competitors

Pacific Smiles Group

ASX:PSQ

AU$311.2m

Regis Healthcare

ASX:REG

AU$2.0b

Ramsay Health Care

ASX:RHC

AU$8.8b

Capitol Health

ASX:CAJ

AU$415.6m

Price History & Performance

Summary of all time highs, changes and price drops for Monash IVF Group
Historical stock prices
Current Share Price	AU$1.17
52 Week High	AU$1.53
52 Week Low	AU$1.12
Beta	1.41
11 Month Change	-3.72%
3 Month Change	-15.88%
1 Year Change	-7.17%
33 Year Change	26.63%
5 Year Change	11.48%
Change since IPO	-38.85%

Recent updates

Shareholder Returns

	MVF	AU Healthcare	AU Market
7D	-1.7%	2.7%	1.5%
1Y	-7.2%	-0.4%	17.3%

Return vs Industry: MVF underperformed the Australian Healthcare industry which returned 0.1% over the past year.

Return vs Market: MVF underperformed the Australian Market which returned 18.3% over the past year.

Price Volatility

Is MVF's price volatile compared to industry and market?
MVF volatility
MVF Average Weekly Movement	4.3%
Healthcare Industry Average Movement	4.9%
Market Average Movement	8.5%
10% most volatile stocks in AU Market	17.4%
10% least volatile stocks in AU Market	3.5%

Stable Share Price: MVF has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: MVF's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2024	997	Michael Knaap	www.monashivfgroup.com.au

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services.

Monash IVF Group Limited Fundamentals Summary

How do Monash IVF Group's earnings and revenue compare to its market cap?
MVF fundamental statistics
Market cap	AU$453.92m
Earnings (TTM)	-AU$6.53m
Revenue (TTM)	AU$255.23m

1.8x

P/S Ratio

-69.5x

P/E Ratio

Is MVF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MVF income statement (TTM)
Revenue	AU$255.23m
Cost of Revenue	AU$169.46m
Gross Profit	AU$85.77m
Other Expenses	AU$92.29m
Earnings	-AU$6.53m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.017
Gross Margin	33.60%
Net Profit Margin	-2.56%
Debt/Equity Ratio	24.1%

How did MVF perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

-298%

Payout Ratio

MVF Stock Overview

Rewards

Risk Analysis

Monash IVF Group Limited Competitors

ASX:PSQ

AU$311.2m

ASX:REG

AU$2.0b

ASX:RHC

AU$8.8b

ASX:CAJ

AU$415.6m

Price History & Performance

Recent News & Updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Recent updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought AU$192k worth of stock

New 90-day low: AU$0.70

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

New 90-day high: AU$0.72

New 90-day high: AU$0.65

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

Shareholder Returns

Price Volatility

About the Company

Monash IVF Group Limited Fundamentals Summary

1.8x

-69.5x

Earnings & Revenue

Dividends

4.3%

-298%